DE Research Update — June 20, 2026 (Updated)
Updated Thesis
Deere & Company is a leading global manufacturer of agricultural, construction, and forestry machinery with a durable competitive moat anchored by its number one market share in large agricultural equipment and a dense dealer network. The company benefits from embedded precision agriculture technology that widens its competitive gap, particularly in North America where it holds 40 to 60 percent market share in high horsepower tractors and combines. Despite strong business quality demonstrated by 18.3 percent return on equity and steady revenue growth of 6.7 percent in the most recent quarter, the stock is currently overvalued trading at a price to sales of 3.39 and a trailing P/E of 33.31, which is expensive relative to its five-year history.
The investment grade as of this refresh is D — solid business quality. High-tier business, expensive valuation with 29.6% downside to $414.61 fair value
Key Metrics at a Glance
- Revenue growth: +6.7% year over year
- Net margin: 10.2%
- Forward P/E: 33.3x
- Fair value upside: -29.6% to our estimate of $415
Current price: $589.24
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Deere & Company remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full DE research →](/stocks/DE)